<DOC>
	<DOC>NCT00417326</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia</brief_summary>
	<brief_title>Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Sivelestat</mesh_term>
	<mesh_term>Glycine</mesh_term>
	<criteria>Patients with communityacquired pneumonia Patients with acute respiratory failure Patients with nosocomial pneumonia Patients on mechanical ventilation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>ONO-5046Na</keyword>
	<keyword>acute respiratory failure</keyword>
	<keyword>community-acquired pneumonia</keyword>
</DOC>